- Home
- FWRD vs IGMS Comparison
FWRD vs IGMS Comparison
Compare FWRD & IGMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FWRD
- IGMS
- Stock Information
- Founded
- FWRD 1981
- IGMS 1993
- Country
- FWRD United States
- IGMS United States
- Employees
- FWRD N/A
- IGMS N/A
- Industry
- FWRD Oil Refining/Marketing
- IGMS Biotechnology: Pharmaceutical Preparations
- Sector
- FWRD Consumer Discretionary
- IGMS Health Care
- Exchange
- FWRD Nasdaq
- IGMS Nasdaq
- Market Cap
- FWRD 980.6M
- IGMS 962.1M
- IPO Year
- FWRD 1993
- IGMS 2019
- Fundamental
- Price
- FWRD $34.52
- IGMS $9.47
- Analyst Decision
- FWRD Hold
- IGMS Hold
- Analyst Count
- FWRD 4
- IGMS 8
- Target Price
- FWRD $30.00
- IGMS $14.63
- AVG Volume (30 Days)
- FWRD 736.6K
- IGMS 238.9K
- Earning Date
- FWRD 11-04-2024
- IGMS 11-08-2024
- Dividend Yield
- FWRD 2.78%
- IGMS N/A
- EPS Growth
- FWRD N/A
- IGMS N/A
- EPS
- FWRD N/A
- IGMS N/A
- Revenue
- FWRD $2,179,844,000.00
- IGMS $2,918,000.00
- Revenue This Year
- FWRD $86.32
- IGMS $298.54
- Revenue Next Year
- FWRD $8.07
- IGMS N/A
- P/E Ratio
- FWRD N/A
- IGMS N/A
- Revenue Growth
- FWRD 78.71
- IGMS 57.64
- 52 Week Low
- FWRD $11.21
- IGMS $4.72
- 52 Week High
- FWRD $67.20
- IGMS $22.50
- Technical
- Relative Strength Index (RSI)
- FWRD 44.34
- IGMS 28.30
- Support Level
- FWRD $33.75
- IGMS $10.91
- Resistance Level
- FWRD $36.93
- IGMS $16.32
- Average True Range (ATR)
- FWRD 2.16
- IGMS 1.53
- MACD
- FWRD -0.22
- IGMS -0.79
- Stochastic Oscillator
- FWRD 44.00
- IGMS 0.80
About FWRD Forward Air Corporation
Forward Air Corp is an asset-light freight and logistics company. The company's operating segment includes Expedited Freight and Intermodal. The company generates maximum revenue from the Expedited Freight segment. The expedited Freight segment operates a comprehensive national network to provide expedited regional, inter-regional, and national LTL (less-than-truckload) services. It also offers customers local pick-up and delivery and other services including final mile, truckload, shipment consolidation and deconsolidation, warehousing, customs brokerage, and other handling. The Company conducts business in the United States, Canada, and Mexico.
About IGMS IGM Biosciences Inc.
IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, Aplitabart: An IgM antibody targeting Death Receptor 5 (DR5) proteins, for the treatment of colorectal cancer; Imvotamab: A bispecific for severe systemic lupus erythematosus (SLE) and one for severe rheumatoid arthritis (RA); and IGM-2644: A bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins, currently planned for evaluation in autoimmune disease.